3 Top Growth Stocks to Buy Today

It's no secret that the biggest financial wins often come from growth stocks. 

They're the revolutionary companies that capture our imagination, often turning a small investment into significant, even life changing gains. Just look at the MAG7 over the last 15 years for proof of that statement. 

But investing is a game of two sides. 

One side is the dream of massive riches, while the other side is profound risk. You can't chase huge returns without accepting the reality that most growth stories don't end well. 

That’s because in a competitive world it is hard to keep an advantage over your competitors for a long time. 

This underscores the necessity of applying a proven quantitative system, like the Zen Ratings, to fully evaluate a stock’s fundamental merits in order to avoid these pitfalls.This points directly to the benefit of our…

Top 7 Growth Stock Strategy

The Zen Ratings is a great starting point for finding great growth stocks. However, on any given day there are 930 Buy rated companies to consider. 

This is precisely why we went back to the Data Science team that created the Zen Ratings to dig deeper. We tasked them with creating more finely tuned strategies that narrowed down to the top 7 stocks and increased performance. 

The 11 strategies they created form the heart of the Zen Strategies service. 

And yes, the Growth strategy they created is one of the best as proven by +37.92% average annual gain going back to 2003. .

It’s easy to point out some of the years with big gains like 2020 and 2021. However, I think the most impressive item here is the +17.51% gain in 2022 in the midst of a bear market. 

Going back to the top of the article, we discussed the risks of owning growth stocks. Case in point was the horrifying -66% loss for the famed Ark Innovation ETF (ARKK) in 2022. 

ARKK is supposed to be the poster child for growth stocks. Yet the risk involved is scary and unnecessary. 

This is precisely why we created the Growth strategy. And the results speak for themselves. 

Now, let’s highlight 3 of the current 7 stocks appearing in this coveted Growth stock list. 

3 Top Growth Stocks

1. OptimizeRx (OPRX)

OptimizeRx is a leading healthtech company that connects pharmaceutical companies with providers and patients. The company uses an AI-driven platform to offer a range of digital marketing and communication solutions to help pharmaceutical companies reach their target audience at critical points during their healthcare journey. 

The company can be likened to an ad-tech platform that serves as a bridge, connecting pharmaceutical companies directly to patients. This business model is highly relevant and solves a major pain point for pharmaceutical companies. 

Many major pharmaceutical companies are looking to directly sell their products to patients. This is in response to President Trump’s desire to lower drug prices while also maintaining margins, and combatting generics and counterfeits.

While this is a powerful catalyst for future growth, the company is already in the midst of an impressive earnings surge. Entering the year, analysts were forecasting 2025 and 2026 full-year EPS of $0.25 and $0.40, respectively. Now, these estimates have been hiked to $0.65 and $0.80, respectively due to steady growth in users and revenue per user. 

In terms of the Zen Ratings, OPRX has an overall rating of Buy (B). Compared to other growth stocks, OPRX is less risky given its reasonable valuations and B ratings for Financials. This score reflects OPRX’s strong balance sheet, manageable debt load, margin expansion, and clear path to profitability. 

2. Xeris Biopharma Holdings (XERS)

Xeris Biopharma focuses on developing and commercializing therapies for people with chronic endocrine and neurological diseases. Its main products are Gvoke, a ready-to-use glucagon injection for severe hypoglycemia in people with diabetes; Keveyis, a FDA-approved treatment for Primary Periodic Paralysis; and Recorlev, a treatment for Cushing's Syndrome. 

Over the past year, XERS has nearly tripled. The primary reason is that the company is in the midst of turning profitable due to strong demand for its products. In 2024, the company posted a full-year loss of -$0.40 per share. But, analysts are expecting a decisive turn towards profitability in 2026. 

The positive sentiment is also evident on Wall Street due to a flurry of upgrades and positive commentary from analysts. In fact, all 4 analysts covering the stock have a Buy rating on it with no Holds or Sells. Their consensus price target is $9.50, a 22% gain from current levels. 

According to Zen Ratings, XERS has an overall Rating of Buy (B). Over the last 23 years, B-rated stocks have outperformed the market by a wide margin with an average annual gain of 19.9% vs 10.5% for the S&P 500.

3. MasTec (MTZ)

MasTec is a leading infrastructure construction company with significant exposure to the communications, energy, and utility sectors. It builds critical electrical infrastructure, such as transmission lines, substations, and smart grid systems and counts major utilities among its customers.

MasTec has an incredible streak of beating analysts’ earnings expectations for 20 straight quarters. The impact of higher capex spending due to AI is evident in recent results. However, the best way to see this is through the trajectory of its 2026 full-year earnings estimates. 

Following Q1 earnings season last year, analysts were forecasting just over $5 per share in earnings. Currently, analysts are projecting $7.60 in 2026 earnings, a more than 50% increase with similar increases in magnitude for 2025 and 2027 full-year earnings as well. 

In terms of the Zen Ratings, MTZ has a Strong Buy (A) rating. A-rated stocks have an average annual performance of 32.5% which handily beats the S&P 500’s average 10.8% gain. 

With this earnings strength, it’s not surprising that MTZ is in the top 1% of all stocks in terms of Growth. Three major factors are MTZ’s consistency in growing earnings, expanding profit margins, and strong free cash flow generation. 

Want More Great Growth Stocks?

The 3 stocks shared above are just a sample of what you will get from our proven Growth Stock strategy. 

That’s because everyday our computers recalculate 115 different factors for every stock. And the top 7 stocks for this proprietary model are shared every day only with Zen Strategies members.

See Top 7 Growth Stocks Here >

But perhaps growth stocks are not your cup of tea. Maybe you prefer Value stocks or Momentum or Income or Stocks Under $10 etc. 

Gladly we have 11 market beat strategies in total. Something for every investor…and every market condition. 

To learn more about how to tap into all these market beating strategies, then watch the presentation below:

77 Best Stocks NOW! >

Want to get in touch? Email us at news@wallstreetzen.com.